Cargando…

Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature

(1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon AP...

Descripción completa

Detalles Bibliográficos
Autores principales: Jerez-Lienas, Alba, Mathian, Alexis, Aboab, Jenifer, Crassard, Isabelle, Hie, Miguel, Cohen-Aubart, Fleur, Haroche, Julien, Wahl, Denis, Cervera, Ricard, Amoura, Zahir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699363/
https://www.ncbi.nlm.nih.gov/pubmed/34942943
http://dx.doi.org/10.3390/brainsci11121641
_version_ 1784620496653910016
author Jerez-Lienas, Alba
Mathian, Alexis
Aboab, Jenifer
Crassard, Isabelle
Hie, Miguel
Cohen-Aubart, Fleur
Haroche, Julien
Wahl, Denis
Cervera, Ricard
Amoura, Zahir
author_facet Jerez-Lienas, Alba
Mathian, Alexis
Aboab, Jenifer
Crassard, Isabelle
Hie, Miguel
Cohen-Aubart, Fleur
Haroche, Julien
Wahl, Denis
Cervera, Ricard
Amoura, Zahir
author_sort Jerez-Lienas, Alba
collection PubMed
description (1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon APS manifestation; the information in the literature about this feature consists of case reports and small case series. Our purpose is to describe the particular characteristics of CVT when occurs as part of the APS and compare our series with the patients published in the literature. (2) Methods: We conducted a retrospective observational study collecting data from medical records in three referral centers for APS and CVT, and a systematic review of the literature for CVT cases in APS patients. (3) Results: Twenty-seven APS patients with CVT were identified in our medical records, the majority of them diagnosed as primary APS and with the CVT being the first manifestation of the disease; additional risk factors for thrombosis were identified. The review of the literature yielded 86 cases, with similar characteristics as those of our retrospective series. (4) Conclusions: To our knowledge, our study is the largest CVT series in APS patients published to date, providing a unique point of view in this rare thrombotic manifestation.
format Online
Article
Text
id pubmed-8699363
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86993632021-12-24 Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature Jerez-Lienas, Alba Mathian, Alexis Aboab, Jenifer Crassard, Isabelle Hie, Miguel Cohen-Aubart, Fleur Haroche, Julien Wahl, Denis Cervera, Ricard Amoura, Zahir Brain Sci Article (1) Background: The Antiphospholipid Syndrome (APS) is a systemic autoimmune disorder characterized by arterial and/or venous thrombosis, pregnancy morbidity and raised titers of antiphospholipid antibodies. Cerebral vein thrombosis (CVT) is a rare form of cerebrovascular accident and an uncommon APS manifestation; the information in the literature about this feature consists of case reports and small case series. Our purpose is to describe the particular characteristics of CVT when occurs as part of the APS and compare our series with the patients published in the literature. (2) Methods: We conducted a retrospective observational study collecting data from medical records in three referral centers for APS and CVT, and a systematic review of the literature for CVT cases in APS patients. (3) Results: Twenty-seven APS patients with CVT were identified in our medical records, the majority of them diagnosed as primary APS and with the CVT being the first manifestation of the disease; additional risk factors for thrombosis were identified. The review of the literature yielded 86 cases, with similar characteristics as those of our retrospective series. (4) Conclusions: To our knowledge, our study is the largest CVT series in APS patients published to date, providing a unique point of view in this rare thrombotic manifestation. MDPI 2021-12-13 /pmc/articles/PMC8699363/ /pubmed/34942943 http://dx.doi.org/10.3390/brainsci11121641 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Jerez-Lienas, Alba
Mathian, Alexis
Aboab, Jenifer
Crassard, Isabelle
Hie, Miguel
Cohen-Aubart, Fleur
Haroche, Julien
Wahl, Denis
Cervera, Ricard
Amoura, Zahir
Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
title Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
title_full Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
title_fullStr Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
title_full_unstemmed Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
title_short Cerebral Vein Thrombosis in the Antiphospholipid Syndrome: Analysis of a Series of 27 Patients and Review of the Literature
title_sort cerebral vein thrombosis in the antiphospholipid syndrome: analysis of a series of 27 patients and review of the literature
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699363/
https://www.ncbi.nlm.nih.gov/pubmed/34942943
http://dx.doi.org/10.3390/brainsci11121641
work_keys_str_mv AT jerezlienasalba cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT mathianalexis cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT aboabjenifer cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT crassardisabelle cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT hiemiguel cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT cohenaubartfleur cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT harochejulien cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT wahldenis cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT cerveraricard cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature
AT amourazahir cerebralveinthrombosisintheantiphospholipidsyndromeanalysisofaseriesof27patientsandreviewoftheliterature